Resilient Biotics
PrivateLast Round
Series A
Jan 29, 2021
Total Funding Raised
$7.1M
Company Overview
Resilient Biotics operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series A round in January 2021.
Resilient Biotics is a biotechnology company developing live biotherapeutics to combat complex respiratory infections in human and animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resilient Biotics Comparables
Compare Resilient Biotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiomEdit | 79% | |
| General Probiotics | 75% | |
| Native Microbials | 70% |
For institutional investors. Book with your work email.
Resilient Biotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 29, 2021 | ||||
| Accelerator | Feb 9, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Resilient Biotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation In Motion | Series A |
| Fulcrum Global Capital | Series A |
| Berkeley Catalyst Fund | Series A |
| Viking Global Investors | Series A |
| Elanco | Series A |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 62% MoM.
- Jan 20, 2026
Monthly visitors increased 863% MoM, reaching 867.
For institutional investors. Book with your work email.
Resilient Biotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Resilient Biotics's valuation, stock price, and market status.
Is Resilient Biotics a public or private company?
Resilient Biotics is a private company.
What is the current stock price of Resilient Biotics?
Resilient Biotics is a private company, so its shares have no public market price. Caplight tracks Resilient Biotics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Resilient Biotics worth (valuation)?
Valuation information for Resilient Biotics is not publicly available.
Can I buy Resilient Biotics stock?
Resilient Biotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Resilient Biotics's last funding round?
Resilient Biotics's most recent funding round was Series A on January 29, 2021.
Who are the main investors in Resilient Biotics?
Key investors in Resilient Biotics include Fulcrum Global Capital, Berkeley Catalyst Fund, Illumina Accelerator.
Will Resilient Biotics IPO soon?
No public IPO plans have been announced for Resilient Biotics.
How can I track Resilient Biotics secondary market activity?
Caplight tracks bids, offers, and trades in Resilient Biotics's shares on secondary markets.